Ping An Good Doctor CEO He Mingke: Promoting Sustained Growth in Commercial Insurance Cooperation Business Through Two Major Initiatives

DoomCanister

2026-03-25 05:51:20

Abstract generation in progress

Daily Economic News Reporter | Tu Yinghao Daily Economic News Editor | Wei Wenyí

Daily Shanghai, March 25 — (Reporter Tu Yinghao) At the performance release conference of Ping An Good Doctor Technology (stock abbreviation: Ping An Good Doctor, HK01833, share price 13.00 HKD, market value 28.099 billion HKD) held that day, Ping An Good Doctor CEO He Mingke responded to a question from the Daily Economic News reporter about “the growth potential of commercial insurance collaboration and future strategic plans.” He stated that the company will strive to promote sustained growth of the commercial insurance collaboration business through two main measures: reducing service costs and further improving high-end customer service quality.

Image source: Photo by Tu Yinghao, Daily Economic News

He Mingke said that currently, the company’s service costs are relatively high, making it difficult to fully cover all customers and provide better benefits. The company will further optimize its cost structure and aim to continuously expand market space. He also pointed out that the industry generally operates on a logic of building customer circles through service systems. By breaking through the quality ceiling of customized premium services, the company can create clear service tiers, thereby promoting the growth of high-net-worth customer groups and strengthening the competitiveness of high-end customer services.

According to the annual report, Ping An Good Doctor aims to achieve total revenue of 5.468 billion RMB in 2025, a year-on-year increase of 13.7%; net profit attributable to the parent company of 380 million RMB, up 366.1%; and adjusted net profit of 414 million RMB, up 161.3%. In terms of business structure, the company’s largest revenue source is the commercial insurance collaboration business (F-end), which generated 3.296 billion RMB, an increase of 11%. The corporate health management business (B-end) recorded revenue of 1.306 billion RMB, up 40.6%, accounting for 23.9% of total revenue, an increase of 4.6 percentage points year-on-year.

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. Operate at your own risk.

Cover image source: Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.